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computerized planimetry, the AAR/total area and IA/AAR ratios were calcu-
lated. All data are expressed as percentage mean and standard error of mean.
Results 10 animals were included in the control group and 9 in the Colchi-
cine group (blinded adjudication). All the animals were successfully operated
and survived at 24 hours. The AAR/total area ratios were respectively
54.44±2.9% in the Colchicine group versus 51.96±4.4% in the control group,
p=n.s. No difference in infarct size could be found in Colchicine treated mice
in comparison to control mice with IA/AAR ratios respectively at 49±3.4%
versus 53.7±5.3%, p=n.s.
Conclusion In conclusion, reduction of infarct size could not be obtained
by treatment with Colchicine at the present concentration after induced myo-
cardial infarction in mice. Further analysis should be performed to evaluate
inflammatory cells accumulation in myocardium and inflammation pathways
as well as LV remodeling. 
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Background The study of the changing levels of microRNAs (miRNAs) in
different biological body environments as diagnostic and prognostic marker
for ST-elavation myocardial infarction (STEMI) calls attention of scientists.
We conducted a research to determine the level of several microRNAs in
blood plasma, isolated monocytes and platelets of STEMI pts in the dynamics
of disease development (the 1st and the 7th days). Into the study we included
the evaluation of some cardiac microRNAs (1, 208a, 208b, 499), inflamma-
tion-related and hypoxic-response microRNA-155 and –210.
Methods 20 STEMI pts (mean age 54,85±2,2 years) were identified in
National Scientific Center Institute of Cardiology M.D. Strazhesko. The
control group included 10 subjects of comparable sex and age without any evi-
dence of coronary artery disease. Expression miRNAs was quantified from
plasma, isolated monocytes and platelets using quantitative Real-Time poly-
merase-chain reaction system.
Results In plasma the microRNA-1 level was significantly higher only on day
7, the microRNA-155 level was lower on the first day and 15 times higher on day
7. In platelets the microRNA-1 level was 4.2 times higher on the first day of
STEMI in comparison with the control group and on day 7 of STEMI returned
to the level of the control group. The changes in monocytes were more revealing:
the microRNA-1 level was higher by 28 times on the first day of STEMI, the
microRNA-208a level was higher by 2 times on day 1 and by 19 times on day 7
of STEMI, and the microRNA-155 level was higher by 17 times on day 1 and by
260 times on day 7 of STEMI in comparison to the control group. 
Conclusions The miRNA distribution is unique amongst blood plasma,
isolated monocytes and platelets in pts with STEMI. Our results show higher
informational content of evaluation of certain miRNAs in isolated cells com-
paring with blood plasma, and expresses the necessity of determining miRNA
levels in the dynamics of STEMI.
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Background Coronary artery disease is influenced by both environmental
and genetic factors. Current evidence shows that the CD40-CD40 ligand
(CD40-CD40L) system plays a crucial role in the development, progression
and outcome of acute coronary syndrome. A single nucleotide polymorphism
(SNP) located at position –1 in the Kozak sequence of the CD40 gene
(rs1883832; C>T) has been associated with the development of acute coronary
syndrome. The purpose of the study was to explore the association between
the C/T (–1) single nucleotide polymorphism in the CD40 gene and myocar-
dial infarction (MI) in the Tunisian male population.
Methods A total of 273 unrelated Tunisian patients with MI and 219
healthy controls were genotyped using the polymerase chain reaction-restric-
tion fragment length polymorphism (PCR-RFLP) method. Clinical parameters
such as fasting serum total cholesterol, high-density lipoprotein cholesterol
(HDL-C), triglycerides, and plasma glucose were detected by autoanalyzer
assay. Weight, height and blood pressure (BP) were measured and body mass
index (BMI) was calculated. 
Results Patients with MI had significantly higher frequency of the TT gen-
otypes compared to controls (12.5% vs. 5.9%; OR=1.43, 95% CI: 1.08 – 1.
89, p=0.011). The MI patient group showed a significant higher frequency of
the T allele compared to the controls (0.33 vs. 0.26; OR=1.45, 95% CI: 1.09
– 1.94, p=0.008). The association between the C/T (–1) single nucleotide
polymorphism in the CD40 gene and MI remained significant after adjustment
for other well-established cardiovascular risk factors.
Conclusion Our study suggests that C/T (–1) single nucleotide polymor-
phism in the CD40 gene might contribute to the susceptibility to MI in the
Tunisian male population. Further replication with larger numbers, and popu-
lations of different ethnicities, are needed to confirm our finding. 
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Introduction Myocardial infarction (MI) is a major cause of morbidity and
mortality and is a main etiology of heart failure. The process of MI is modu-
lated by the inflammatory response. Many studies have shown a significant
inflammatory response phenomenon in pathogenesis of MI.
Objectives The aim of this study is to discuss the role of pro-inflammatory
(IL8,TNFα) and anti-inflammatory (IL10) cytokines that are among others
decried involved in the process of remodeling post-myocardial infarction.
Methods Prospective, monocentric case-control study that included
82 patients diagnosed with a first episode of myocardial infarction and low
LVEF and 30 healthy subjects.The quantification of IL10 was based on the
technique of sandwich ELISA. The CLIA technique was used for quantifica-
tion of IL8 and TNFα.All patients were evaluated by an echocardiography
after revascularisation and one month after to study cardiac remodeling.
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